PL2685994T3 - Bakterie probiotyczne wykazujące aktywność przeciwutleniającą i ich zastosowanie - Google Patents

Bakterie probiotyczne wykazujące aktywność przeciwutleniającą i ich zastosowanie

Info

Publication number
PL2685994T3
PL2685994T3 PL11719626T PL11719626T PL2685994T3 PL 2685994 T3 PL2685994 T3 PL 2685994T3 PL 11719626 T PL11719626 T PL 11719626T PL 11719626 T PL11719626 T PL 11719626T PL 2685994 T3 PL2685994 T3 PL 2685994T3
Authority
PL
Poland
Prior art keywords
antioxidant activity
probiotic bacteria
probiotic
bacteria
antioxidant
Prior art date
Application number
PL11719626T
Other languages
English (en)
Inventor
Giovanni Mogna
Gian Paolo Strozzi
Luca Mogna
Original Assignee
Probiotical Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Probiotical Spa filed Critical Probiotical Spa
Publication of PL2685994T3 publication Critical patent/PL2685994T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Emergency Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Psychology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Vascular Medicine (AREA)
PL11719626T 2011-03-17 2011-03-17 Bakterie probiotyczne wykazujące aktywność przeciwutleniającą i ich zastosowanie PL2685994T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/IB2011/000561 WO2012123770A1 (en) 2011-03-17 2011-03-17 Probiotic bacteria having antioxidant activity and use thereof
EP11719626.1A EP2685994B1 (en) 2011-03-17 2011-03-17 Probiotic bacteria having antioxidant activity and use thereof

Publications (1)

Publication Number Publication Date
PL2685994T3 true PL2685994T3 (pl) 2016-05-31

Family

ID=44120141

Family Applications (1)

Application Number Title Priority Date Filing Date
PL11719626T PL2685994T3 (pl) 2011-03-17 2011-03-17 Bakterie probiotyczne wykazujące aktywność przeciwutleniającą i ich zastosowanie

Country Status (10)

Country Link
US (1) US20140065116A1 (pl)
EP (1) EP2685994B1 (pl)
JP (1) JP2014508186A (pl)
CN (1) CN103582486B (pl)
BR (1) BR112013023600A2 (pl)
DK (1) DK2685994T3 (pl)
ES (1) ES2561253T3 (pl)
PL (1) PL2685994T3 (pl)
RU (1) RU2572698C2 (pl)
WO (1) WO2012123770A1 (pl)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20110791A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri in grado di metabolizzare gli ossalati.
ITMI20110793A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri probiotici e composizione sinbiotica contenente gli stessi destinata alla alimentazione dei neonati.
ITMI20110792A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri appartenenti al genere bifidobacterium per uso nel trattamento della ipercolesterolemia.
ITMI20111718A1 (it) 2011-09-23 2013-03-24 Probiotical Spa Un materiale impermeabile alla umidita e allo ossigeno per confezionare prodotti dietetici, cosmetici e specialita medicinali.
WO2014141265A1 (en) * 2013-03-14 2014-09-18 Nofar Gil Inhibition of neurodegenerative disease by grape seed extract, green tea extract and probiotic bacteria
US20160106789A1 (en) * 2013-03-14 2016-04-21 Gil NOFAR Inhibition of Neurodegenerative Disease by Grape Seed Extract, Green Tea Extract and Probiotic Bacteria
ITMI20130793A1 (it) 2013-05-14 2014-11-15 Probiotical Spa Composizione comprendente batteri lattici per uso nel trattamento preventivo e/o curativo delle cistiti ricorrenti.
ES2526986B1 (es) * 2013-07-18 2015-11-02 Biopolis, S.L. Nueva cepa de Bifidobacterium animalis subsp. lactis CECT 8145 y su uso para el tratamiento y/o prevención de sobrepeso y obesidad y enfermedades asociadas
CN103961338B (zh) * 2014-04-03 2016-01-06 浙江大学 羟基酪醇在抗阿霉素心肌毒性中的应用及以羟基酪醇为主要活性成分的药物组合物
CN104172177A (zh) * 2014-06-11 2014-12-03 南通昊友食品添加剂有限公司 一种食品抗氧化剂的生产方法
MX2016016773A (es) * 2014-07-01 2017-06-30 Probi Usa Inc Comprimidos probióticos bicapa de doble liberacion.
SG11201701577WA (en) * 2014-08-29 2017-04-27 Wakamoto Pharma Co Ltd Lactic acid bacteria-containing composition
CN104522833A (zh) * 2014-12-16 2015-04-22 镇江拜因诺生物科技有限公司 一种微生物食品抗氧化剂的制备方法
TWI759260B (zh) * 2015-01-02 2022-04-01 美商梅拉洛伊卡公司 多元補充品組成物
TWI829098B (zh) 2015-01-02 2024-01-11 美商梅拉洛伊卡公司 細菌組成物
WO2016109853A2 (en) 2015-01-02 2016-07-07 Melaleuca, Inc. Dietary supplement compositions
KR101806130B1 (ko) * 2015-05-07 2017-12-08 주식회사 다인소재 유산균발효분말과 허브 추출물을 유효성분으로 하는 육가공용 항균 및 항산화 조성물
US9839624B2 (en) * 2015-09-23 2017-12-12 Reoxcyn Discoveries Group, Inc. Flavonoid compositions and methods of use
RU2617946C1 (ru) * 2015-11-24 2017-04-28 Автономная Некоммерческая Организация "Научно-Исследовательский Центр Биотехнологии Антибиотиков И Других Биологически Активных Веществ "Биоан" Штаммы Lactobacillus brevis и Lactobacillus rhamnosus с установленной последовательностью генома, синтезирующие глутатион и комплекс внутриклеточных антиоксидантов
CN106473148A (zh) * 2016-09-14 2017-03-08 吴卓蓉 一种复合益生菌组合物及其制备方法及应用
IT201700068000A1 (it) * 2017-06-19 2018-12-19 Probiotical Spa Composizione di batteri e/o loro derivati la cui attività biologica è stata specificatamente studiata per il miglioramento dello stato di salute differenziato per maschi e femmine
CN107593929A (zh) * 2017-10-13 2018-01-19 东北农业大学 一种含有双歧杆菌和嗜酸乳杆菌的抗氧化契达干酪及其制备方法
CN107595921A (zh) * 2017-10-24 2018-01-19 南昌大学 一种复合益生菌发酵的仙人掌果制剂及其在治疗口腔溃疡中的应用
TWI693026B (zh) * 2019-01-07 2020-05-11 大江生醫股份有限公司 黑色素材發酵物及其製備方法與其用於增加抗氧化活性及保護眼睛的用途
IT202000007690A1 (it) * 2020-04-09 2021-10-09 Probiotical Spa Uso di ceppi di batteri Lactobacillus plantarum e/o Lactobacillus pentosus nella riduzione di una quantità ingerita o accumulata di fosfonati nel microbiota umano
US20230217979A1 (en) * 2022-01-13 2023-07-13 Amare Global Nutritional supplements and methods of nutritional supplementation affecting weight loss
CN115944085A (zh) * 2022-12-07 2023-04-11 山东奥博森生物药业股份有限公司 一种功能性益生菌组合物及定量添加装置

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3819838A (en) * 1970-08-04 1974-06-25 Bush Boake Allen Ltd Encapsulated flavoring composition
CH637297A5 (fr) * 1978-12-05 1983-07-29 Nestle Sa Microbille comprenant un microorganisme et son procede de fabrication.
US4670272A (en) * 1985-11-08 1987-06-02 Frito-Lay, Inc. Thermostable creme
RU2268069C2 (ru) * 2000-04-18 2006-01-20 Сосьете Де Продюи Нестле С.А. Питательные модули
WO2004101770A1 (en) * 2003-03-13 2004-11-25 Universite De Moncton (Bureau De Soutien A L'innovation) Antioxidant producing bacterium and uses thereof
DE50300325D1 (de) * 2003-11-03 2005-03-31 Peter-Hansen Volkmann Vaginalpflegezusammensetzung
KR100661032B1 (ko) * 2005-04-19 2006-12-22 주식회사한국야쿠르트 간 기능 개선, 혈중 알코올 감소 및 항산화에 유효한조성물
EP2210505A1 (en) * 2009-01-27 2010-07-28 Nestec S.A. Composition comprising caftaric acid and/or derivatives thereof
IT1400821B1 (it) * 2009-03-09 2013-07-02 Probiotical Spa Sospensione oleosa contenente batteri probiotici per uso pediatrico

Also Published As

Publication number Publication date
EP2685994A1 (en) 2014-01-22
JP2014508186A (ja) 2014-04-03
RU2572698C2 (ru) 2016-01-20
CN103582486B (zh) 2016-11-16
US20140065116A1 (en) 2014-03-06
ES2561253T3 (es) 2016-02-25
RU2013144267A (ru) 2015-04-27
EP2685994B1 (en) 2015-12-30
WO2012123770A1 (en) 2012-09-20
CN103582486A (zh) 2014-02-12
DK2685994T3 (en) 2016-02-01
BR112013023600A2 (pt) 2017-03-01

Similar Documents

Publication Publication Date Title
PL2685994T3 (pl) Bakterie probiotyczne wykazujące aktywność przeciwutleniającą i ich zastosowanie
HK1201208A1 (en) Probiotic bacteria
HK1216322A1 (zh) 組糖基轉移酶及其應用
IL233051B (en) Anti-phf-tau antibodies and uses thereof
HK1199694A1 (zh) 益生菌組合物和方法
IL231244A (en) Conjugated pyrimidine analyzed and used
IL221511A (en) Arilatriazolones associated with bis aryl and their use
EP2818149A4 (en) WHEELCHAIR AND BED INCLUDING
ZA201300612B (en) Novel bacteria and methods of use thereof
ZA201405858B (en) Recombinant microorganisms and methods of use thereof
EP2695894A4 (en) MODIFIED LAMININ AND USE THEREOF
ZA201208173B (en) Peptices and their use
IL229844B (en) Anti-psgl-1 antibodies and their use
GB201111705D0 (en) Compounds and their use
HK1191034A1 (en) N-carboxyalkyl-auristatins and use thereof n-
AP3768A (en) Asymmetric ureas and medical uses thereof
HUE038336T2 (hu) Módosított gram-pozitív baktériumok és alkalmazásaik
EP2688588A4 (en) FAST AND LONG-TERM IMMUNOLOGICAL THERAPEUTIC
HK1198137A1 (en) Disinfecting formulations and uses thereof
GB201111630D0 (en) Novel compounds and their use
EP2768797A4 (en) NEW MODIFIED CLASSICS AND ITS USES
EP2697386A4 (en) DESIGN AND USE OF PEPDUCINE
GB201114448D0 (en) Compounds and their use
HUE038830T2 (hu) Módosított gram-pozitív baktériumok és alkalmazásaik
EP2693879A4 (en) MIGRASTATINES AND THEIR USES